Thang N Tran

A revisit of RSEM generative model and its EM algorithm for quantifying transcript abundances

Son K. Pham, Thao T. Truong, Hy Vuong, 2018 .

Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer

S. O'toole, C. Selinger, M. Kohonen-Corish, 2014, Journal of Clinical Pathology.

PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma.

J. Madore, R. Scolyer, S. O'toole, 2015, Lung cancer.

Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.

S. O'toole, C. Selinger, M. Kohonen-Corish, 2013, Lung cancer.

Screening for ROS1 gene rearrangements in non‐small‐cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target

N. Pavlakis, S. O'toole, A. Gill, 2017, Histopathology.

A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma

N. Pavlakis, G. Reid, S. Clarke, 2016, British Journal of Cancer.

Hera-T: an efficient and accurate approach for quantifying gene abundances from 10X-Chromium data with high rates of non-exonic reads

Son K. Pham, Thao T. Truong, Hy Vuong, 2019, bioRxiv.

Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.

S. O'toole, C. Selinger, M. Kohonen-Corish, 2016, Clinical lung cancer.